摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-Chloro-2-ethylimidazo[1,2-b]pyridazine | 189116-22-1

中文名称
——
中文别名
——
英文名称
6-Chloro-2-ethylimidazo[1,2-b]pyridazine
英文别名
——
6-Chloro-2-ethylimidazo[1,2-b]pyridazine化学式
CAS
189116-22-1
化学式
C8H8ClN3
mdl
——
分子量
181.62
InChiKey
OXTBKBDNMMOMOW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    12
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.25
  • 拓扑面积:
    30.2
  • 氢给体数:
    0
  • 氢受体数:
    2

文献信息

  • [EN] PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF<br/>[FR] INHIBITEURS DE LA PRMT5 CONTENANT UNE DIHYDRO- OU TÉTRAHYDRO-ISOQUINOLÉINE ET LEURS UTILISATIONS
    申请人:EPIZYME INC
    公开号:WO2014100730A1
    公开(公告)日:2014-06-26
    Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5- mediated disorders are also described.
    本文描述了式(A)的化合物,其药学上可接受的盐以及药物组合物。本发明的化合物对抑制PRMT5活性是有用的。还描述了利用这些化合物治疗PRMT5介导的疾病的方法。
  • [EN] NICOTINAMIDE DERIVATIVES<br/>[FR] DÉRIVÉS DE NICOTINAMIDE
    申请人:PFIZER LTD
    公开号:WO2009153721A1
    公开(公告)日:2009-12-23
    The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are defined herein, to compositions containing such compounds and to the uses of such compounds for the treatment of allergic and respiratory conditions.
    本发明涉及式(I)化合物及其药用可接受的盐和溶剂化物,其中取代基在此处定义,含有此类化合物的组合物,以及使用此类化合物治疗过敏和呼吸系统疾病的用途。
  • Fused heterocyclic sulfonylurea compound herbicide containing the same and method of controlling weed with the same
    申请人:Tanaka Yasushi
    公开号:US20050032650A1
    公开(公告)日:2005-02-10
    The present invention provides a compound represented by the formula: wherein Q represents a fused heterocyclic group, X and Y are the same or different and each represent an optionally halogenated lower alkyl group, an optionally halogenated lower alkoxy group, etc., or a salt thereof, as well as a herbicide comprising the compound or a salt thereof, which exhibits a significant effect for control of sulfonylurea herbicide-resistant weeds in paddy fields and can reduce the number of active ingredients in a combined preparation and a method of controlling sulfonylurea herbicide-resistant weeds which comprises using the same.
    本发明提供了一种由以下式子表示的化合物:其中Q代表融合的杂环基团,X和Y相同或不同,每个代表可选的卤代低烷基,可选的卤代低烷氧基等,或其盐,以及包含该化合物或其盐的除草剂,在稻田中对磺酰脲除草剂耐药杂草具有显著的控制效果,可以减少联合制剂中的活性成分数量,并且包括使用该化合物的控制磺酰脲除草剂耐药杂草的方法。
  • Imine Compound
    申请人:Saito Shiuji
    公开号:US20080312435A1
    公开(公告)日:2008-12-18
    An imine compound represented by the formula: wherein A represents a heterocyclic group; R 1 , R 2 , an R 3 each represent a hydrogen atom, a halogen atom, a C 1-10 alkyl group optionally substituted with an aryl group(s) substituted with a halogen atom(s), a C 3-10 cycloalkyl group, a C 1-6 haloalkyl group, a C 1-10 alkoxy group, etc.; R 4 represents an optionally substituted C 1-10 alkyl, C 2-6 alkenyl, or aryl group; R 5 represents a hydrogen atom, a C 1-10 alkoxy group, a C 1-6 haloalkyl group, an optionally substituted C 1-10 alkyl or C 2-6 alkenyl group, an optionally substituted aryl or heterocyclic group, etc.; W represents —CO—, —CO—CO—, —CO—NH—, —CS—NH—, or —SO 2 —, or a cannabinoid-receptor agonist comprising said imine compound as an active ingredient. The imine compound of the present invention has a cannabinoid-receptor agonist effect, and is useful as a therapeutic or prophylactic drug for pains and autoimmune diseases.
    一种以以下式表示的亚胺化合物:其中A代表杂环基团;R1、R2和R3分别表示氢原子、卤素原子、C1-10烷基,该烷基可选地取代有芳基,所述芳基取代有卤素原子,C3-10环烷基,C1-6卤代烷基,C1-10烷氧基等;R4表示可选地取代的C1-10烷基,C2-6烯基或芳基;R5表示氢原子,C1-10烷氧基,C1-6卤代烷基,可选地取代的C1-10烷基或C2-6烯基,可选地取代的芳基或杂环基团等;W表示—CO—,—CO—CO—,—CO—NH—,—CS—NH—或—SO2—,或以该亚胺化合物为活性成分的大麻素受体激动剂。本发明的亚胺化合物具有大麻素受体激动剂作用,可用作治疗或预防疼痛和自身免疫性疾病的药物。
  • Nicotinamide Derivatives
    申请人:Crawforth James Michael
    公开号:US20110306597A1
    公开(公告)日:2011-12-15
    The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, wherein the substituents are defined herein, to compositions containing such compounds and to the uses of such compounds for the treatment of allergic and respiratory conditions.
    本发明涉及公式(I)的化合物及其药学上可接受的盐和溶剂,其中取代基在此定义,以及包含这种化合物的组合物,以及这种化合物用于治疗过敏和呼吸系统疾病的用途。
查看更多